Are you Dr. Rashid?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2727 Bolton Boone Dr
Ste 112
Desoto, TX 75115Phone+1 214-884-7525Fax+1 214-884-7551
Summary
- Dr. Abdul Rashid, MD is a cardiologist in Desoto, Texas. He is currently licensed to practice medicine in Texas, Tennessee, and Kentucky. He is affiliated with Crescent Medical Center Lancaster.
Education & Training
- University of Louisville School of MedicineFellowship, Interventional Cardiology, 2010 - 2011
- University of Louisville School of MedicineFellowship, Cardiovascular Disease, 2007 - 2010
- King Edward Medical UniversityClass of 2001
Certifications & Licensure
- TX State Medical License 2023 - 2026
- KY State Medical License 2007 - 2025
- TN State Medical License 2011 - 2025
- OH State Medical License 2006 - 2007
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases Start of enrollment: 2013 Jun 14
Publications & Presentations
PubMed
- 53 citationsDevice Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis.Rahman Shah, Mannu Nayyar, Ion S. Jovin, Abdul Rashid, Beatrix Ramos Bondy
Annals of Internal Medicine. 2018-03-06 - 4 citationsA meta-analysis of optimal medical therapy with or without percutaneous coronary intervention in patients with stable coronary artery disease.Rahman Shah, Mannu Nayyar, Francis K. Le, Ajay Labroo, Abrar Nasr
Coronary Artery Disease. 2021-04-19 - 3 citationsA Meta-analysis of Clinical Trials Evaluating the Impact of Bivalirudin-based Anticoagulation for Primary Percutaneous Coronary on Long-Term Mortality.Pooja S. Jagadish, Francis K. Le, Ajay Labroo, Abrar Nasr, Abdul Rashid
Journal of Cardiovascular Pharmacology. 2021-07-01
Press Mentions
- CJP Chides Officials over Shoddy StentsFebruary 8th, 2017
Professional Memberships
- Member